Report of Foreign Issuer (6-k)
January 04 2018 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2018
______________-
Commission File Number: 001-36582
Auris Medical Holding AG
(Exact
name of registrant as specified in its charter)
Bahnhofstrasse
21
6300 Zug,
Switzerland
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
INCORPORATION
BY REFERENCE
Exhibit 99.1 to this Report on
Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Numbers 333-206710
and 333-217305) and Form S-8 (Registration Numbers 333-198037, 333-200805 and 333-217306) of Auris Medical Holding AG and to be
a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently
filed or furnished.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Auris Medical Holding AG
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Thomas Meyer
|
|
|
|
|
Name:
|
Thomas Meyer
|
|
|
|
|
Title:
|
Chief Executive Officer
|
Date:
January 4, 2018
EXHIBIT
INDEX
Exhibit Number
|
Description
|
99.1
|
Press Release dated January 4, 2018
|
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Auris Medical (NASDAQ:EARS)
Historical Stock Chart
From Sep 2023 to Sep 2024